Overview: Intrinsic Factor Antibody TestIntroduction: The Intrinsic Factor Antibody Test detects intrinsic factor antibodies to diagnose pernicious anemia, causing fatigue or weakness. Following 2023 ASH guidelines, it uses immunoassay for high specificity, supporting hematological screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in serology for patients with suspected pernicious anemia or vitamin B12 deficiency.
Other Names: IF Antibody Assay, Pernicious Anemia Test.
FDA Status: Laboratory-developed test (LDT), meeting serology standards for diagnostic accuracy.
Historical Milestone: Intrinsic factor antibody testing began in the 1960s with pernicious anemia research. Immunoassay-based methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Detects intrinsic factor antibodies to diagnose pernicious anemia, guides treatment, and evaluates patients with fatigue or weakness.
Test Parameters: 1. Intrinsic Factor Antibodies
Pretest Condition: No fasting required. Collect serum or saliva. Report history of fatigue, weakness, or neurological symptoms.
Specimen: Serum (SST, 2-5 mL), Saliva (sterile container, 1-2 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document fatigue, weakness, neurological symptoms, or family history of pernicious anemia. Include current medications, especially vitamin B12.
Consent: Written consent required, detailing the tests purpose, anemia implications, and risks of blood or saliva collection.
Procedural Considerations: Uses immunoassay to detect intrinsic factor antibodies in serum or saliva. Results are available in 1-2 days, supporting rapid clinical decisions. Performed in laboratories, often for pernicious anemia diagnosis.
Factors Affecting Result Accuracy: Hemolysis, lipemia, or improper sample storage can affect results. Insufficient sample volume may reduce accuracy.
Clinical Significance: Positive intrinsic factor antibodies confirm pernicious anemia, guiding vitamin B12 therapy. Negative results may require further B12 deficiency testing.
Specialist Consultation: Consult a hematologist or gastroenterologist for result interpretation and treatment planning.
Additional Supporting Tests: Vitamin B12 levels, parietal cell antibodies, or Schilling test to confirm pernicious anemia diagnosis.
Test Limitations: Not specific to pernicious anemia; other autoimmune conditions may produce antibodies. Clinical correlation is needed.
References: ASH Anemia Guidelines, 2023; Blood, Carmel R, 2022.
